Vericel (VCEL) Tops Q2 EPS by 13c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LRCX
6. LVS
7. SAP
8. CSX
9. SPY
10. KNX

Go back to Vericel (VCEL) Tops Q2 EPS by 13c

Vericel Reports Second-Quarter 2017 Financial Results

August 9, 2017 7:00 AM EDT

Revenue of $17.0 Million Represents a 32% Increase Over Second Quarter 2016

Results Driven by Momentum of MACI Uptake Following Launch

 Conference Call Today at 8:00am Eastern Time

CAMBRIDGE, Mass., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, today reported financial results for the second quarter ended June 30, 2017.      

Total GAAP net revenues for the quarter ended June 30, 2017 were approximately $17.0 million and included... More